Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 61 - 80 of 444 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of IPI-145 in Patients with Advanced Hematologic Cancers
[Protocol 12-088]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193]
Wexler, Leonard
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Melanoma
  • Sarcomas
A Phase I Study of Iso-Fludelone in Patients with Advanced Solid Tumors
[Protocol 10-202]
Gounder, Mrinal
A Phase I Study of KPT-330 in Patients with Advanced or Metastatic Solid Tumors
[Protocol 12-258]
Gerecitano, John
  • Solid Tumors
A Phase I Study of LDE225 with Etoposide and Cisplatin for the Initial Treatment of Extensive Small Cell Lung Cancer
[Protocol 11-206]
Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other
A Phase I Study of LDK378 in Adults with Non-Small Cell Lung Cancers Containing an ALK Gene Fusion
[Protocol 11-055]
Riely, Gregory
  • Lung Cancer
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase I Study of LY3023414 in Patients with Advanced Cancer
[Protocol 12-286]
Hyman, David
  • Solid Tumors
A Phase I Study of MED14736 in Patients with Advanced Solid Tumors
[Protocol 12-179]
Segal, Neil
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038]
Kernan, Nancy
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of MORAb-004 in Patients with Solid Tumors
[Protocol 10-012]
Carvajal, Richard
A Phase I Study of Narnatumab (IMC-RON8) in Patients with Refractory Solid Tumors
[Protocol 13-018]
Gounder, Mrinal
  • Solid Tumors
A Phase I Study of Oral DS-7423 in Patients with Advanced Solid Tumors
[Protocol 11-144]
Ho, Alan
A Phase I Study of Oral LEE011 in Patients with Advanced Solid Tumors or Lymphomas
[Protocol 10-211]
Gerecitano, John
  • Lymphoma
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020]
Meyers, Paul
A Phase I Study of Pegylated Liposomal Doxorubicin, Carboplatin, and Veliparib in Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
[Protocol 12-197]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085]
Segal, Neil
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208]
Trippett, Tanya
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Lymphoblastic Leukemia
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156]
Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
  • Thyroid Cancer
A Phase I Study of PU-H71 in Patients with Advanced Cancer
[Protocol 11-041]
Gerecitano, John
  • Lymphoma
A Phase I Study of SGN-CD19A in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
[Protocol 12-282]
Moskowitz, Craig
  • Lymphoma
    • Non-Hodgkin's Lymphoma